Abstract Deadline Extended for CBS/CSPS/CC-CRS Conference
0 comments
by
Dear members and friends of the Canadian Biomaterials Society, The abstract deadline has been extended to March 2nd, 2026 for the upcoming CBS CCPS cc-CRS 2026 meeting this June in Vancouver, BC...
Dear friends , For this years annual meeting in beautiful Vancouver, BC June 2 - 5 2026 we are happy to partner with the Canadian Society for Pharmaceutical Sciences CSPS and the Canadian Chapter of the Controlled Release Society cc-CRS ...
Call for Abstracts for CBS/CSPS/cc-CRS Conference is now open!
0 comments
by
Call for Abstracts is OPEN The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Save the Date for CBS2026! June 2–5, 2026
0 comments
by
Overview The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Uncontrolled bleeding causes significant morbidities and mortalities worldwide1. The native blood coagulation is insufficient to halt severe bleeding due to the slow process 2-8 minutes and the weak mechanical properties of blood clots...
Manipulation of Nanocomposite Phase Behaviour upon Inclusion of a Calcium Salt and Evaluation of the Resulting First Generation Nanocomposite Ink with MG63 Cells
comments
In the area of cancer research, a major issue with conventional 2D cell culture is that it cannot reproduce complex in vivo cell-extracellular matrix ECM interactions, nor those between cancer epithelial cells and stromal compartment, which play a crucial role in tumorigenesis and progression...
Two problems arise when replacing a patient artery by a synthetic vascular graft VG . The first one is the absence of endothelial lining on the lumen side of the graft, related to the inappropriate surface properties and textures, which leads to VG thrombosis...
Traditionally, controlled release from local delivery vehicles has involved diffusion-based strategies, where an encapsulated therapeutic diffuses slowly out of a nanoparticle...
